| DIRECT COMPETITOR COMPARISON | |
| TSPT | Pvt1 | NEXM | PTIE | Industry | | Market Cap: | 86.66M | N/A | 30.49M | 222.97M | 98.96M | | Employees: | N/A | 351 | 13 | 48 | 65 | | Qtrly Rev Growth (yoy): | N/A | N/A | -64.20% | -87.60% | 19.10% | | Revenue (ttm): | 2.08M | 1.10M1 | 6.18M | 25.08M | 13.84M | | Gross Margin (ttm): | 100.00% | N/A | 53.09% | -5.42% | 65.67% | | EBITDA (ttm): | -20.62M | N/A | 171.50K | -7.66M | -12.25M | | Oper Margins (ttm): | -1,015.79% | N/A | -3.75% | -31.75% | -149.46% | | Net Income (ttm): | -25.58M | -43.50M1 | -792.20K | -4.56M | N/A | | EPS (ttm): | -2.249 | N/A | -0.009 | -0.108 | -0.31 | | P/E (ttm): | N/A | N/A | N/A | N/A | 17.51 | | PEG (5 yr expected): | N/A | N/A | N/A | N/A | 1.28 | | P/S (ttm): | 41.60 | N/A | 4.93 | 8.89 | 10.12 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.35 | 0.00% | 58.05B | 12.51 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 52.16 | 0.00% | 15.08B | 17.46 | | Genzyme Corp. | GENZ | 48.20 | 0.00% | 12.79B | 27.48 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 43.01 | 0.00% | 38.71B | 16.63 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.82 | 0.00% | 9.24B | 1057.55 | | Teva Pharmaceutical Industries Limited | TEVA | 55.98 | 0.00% | 49.32B | 51.22 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.80 | 0.00% | 4.22B | 20.52 | | King Pharmaceuticals Inc. | KG | 12.24 | 0.00% | 3.04B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.74 | 0.00% | 5.73B | 114.97 | | Pfizer Inc. | PFE | 18.58 | 0.00% | 149.93B | 15.43 | | Johnson & Johnson | JNJ | 64.57 | 0.00% | 178.16B | 14.10 | | GlaxoSmithKline plc | GSK | 42.09 | 0.00% | 106.70B | 13.80 | | Sanofi-Aventis | SNY | 39.70 | 0.00% | 103.66B | N/A | | Novartis AG | NVS | 54.60 | 0.00% | 124.01B | 16.35 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 42.80 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.97 | 0.00% | 66.66B | 9.23 | | Abbott Laboratories | ABT | 54.09 | 0.00% | 83.66B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.70 | 0.00% | 50.91B | 13.30 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | NEXM | | NEXMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Tue, Dec 22 -
EDGAR Online | | • | NEXM | | NexMed Granted Continued Listing on NASDAQ
Fri, Dec 18 -
Business Wire | | • | NEXM | | NEXMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition o
Thu, Dec 17 -
EDGAR Online | | • | NEXM | | NexMed, Inc. Leases Its Facility in New Jersey
Thu, Dec 17 -
Business Wire | | • | NEXM | | NexMed Closes Acquisition of Bio-Quant
Mon, Dec 14 -
Business Wire | | • | PTIE | | 5 Stocks Bouncing Back
Fri, Dec 11 -
at Motley Fool | | • | PTIE | | Today's 5-Star Movers
Fri, Dec 4 -
at Motley Fool | | • | PTIE | | King Beats, but Earnings Down
Thu, Nov 5 -
Zacks.com | | • | PTIE | | PAIN THERAPEUTICS INC Financials
Wed, Nov 4 -
EDGAR Online Financials | | • | PTIE | | Pain Therapeutics to Present at the Credit Suisse Healthcare Conference
Wed, Nov 4 -
GlobeNewswire | | • | PTIE | | PAIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
Fri, Oct 30 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|
0.01% Nasdaq 0.00%
Competitors
